Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.04
OMCM's Cash to Debt is ranked lower than
96% of the 1806 Companies
in the Global Health Information Services industry.

( Industry Median: 8.17 vs. OMCM: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
OMCM' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: N/A
Current: 0.04
Equity to Asset -4.58
OMCM's Equity to Asset is ranked lower than
99% of the 1719 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. OMCM: -4.58 )
Ranked among companies with meaningful Equity to Asset only.
OMCM' s Equity to Asset Range Over the Past 10 Years
Min: -17.38  Med: -6.05 Max: -0.05
Current: -4.58
-17.38
-0.05
Interest Coverage 0.18
OMCM's Interest Coverage is ranked lower than
100% of the 1173 Companies
in the Global Health Information Services industry.

( Industry Median: 613.26 vs. OMCM: 0.18 )
Ranked among companies with meaningful Interest Coverage only.
OMCM' s Interest Coverage Range Over the Past 10 Years
Min: 0.27  Med: 0.27 Max: 0.27
Current: 0.18
F-Score: 2
Z-Score: -12.31
M-Score: -2.81
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 2.52
OMCM's Operating margin (%) is ranked lower than
59% of the 1762 Companies
in the Global Health Information Services industry.

( Industry Median: 4.75 vs. OMCM: 2.52 )
Ranked among companies with meaningful Operating margin (%) only.
OMCM' s Operating margin (%) Range Over the Past 10 Years
Min: -140.06  Med: -46.83 Max: 3.86
Current: 2.52
-140.06
3.86
Net-margin (%) -2.06
OMCM's Net-margin (%) is ranked lower than
68% of the 1763 Companies
in the Global Health Information Services industry.

( Industry Median: 3.38 vs. OMCM: -2.06 )
Ranked among companies with meaningful Net-margin (%) only.
OMCM' s Net-margin (%) Range Over the Past 10 Years
Min: -168.98  Med: -67.41 Max: -22.06
Current: -2.06
-168.98
-22.06
ROA (%) -6.62
OMCM's ROA (%) is ranked lower than
74% of the 1810 Companies
in the Global Health Information Services industry.

( Industry Median: 3.01 vs. OMCM: -6.62 )
Ranked among companies with meaningful ROA (%) only.
OMCM' s ROA (%) Range Over the Past 10 Years
Min: -978.32  Med: -210.76 Max: -84.23
Current: -6.62
-978.32
-84.23
ROC (Joel Greenblatt) (%) 420.27
OMCM's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 1778 Companies
in the Global Health Information Services industry.

( Industry Median: 22.73 vs. OMCM: 420.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMCM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4027.27  Med: -709.06 Max: -105.97
Current: 420.27
-4027.27
-105.97
Revenue Growth (3Y)(%) 4.00
OMCM's Revenue Growth (3Y)(%) is ranked lower than
53% of the 1367 Companies
in the Global Health Information Services industry.

( Industry Median: 4.90 vs. OMCM: 4.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMCM' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -58.1  Med: 11.90 Max: 81.7
Current: 4
-58.1
81.7
EPS Growth (3Y)(%) 5.90
OMCM's EPS Growth (3Y)(%) is ranked higher than
50% of the 1027 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. OMCM: 5.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMCM' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.7  Med: -12.60 Max: 19.1
Current: 5.9
-47.7
19.1
» OMCM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OMCM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 1.17
OMCM's P/S is ranked higher than
62% of the 2326 Companies
in the Global Health Information Services industry.

( Industry Median: 1.64 vs. OMCM: 1.17 )
Ranked among companies with meaningful P/S only.
OMCM' s P/S Range Over the Past 10 Years
Min: 0.19  Med: 1.45 Max: 10.14
Current: 1.17
0.19
10.14
EV-to-EBIT 18.49
OMCM's EV-to-EBIT is ranked lower than
55% of the 1767 Companies
in the Global Health Information Services industry.

( Industry Median: 16.73 vs. OMCM: 18.49 )
Ranked among companies with meaningful EV-to-EBIT only.
OMCM' s EV-to-EBIT Range Over the Past 10 Years
Min: -56.2  Med: -5.20 Max: 46.6
Current: 18.49
-56.2
46.6
EV-to-EBITDA 16.62
OMCM's EV-to-EBITDA is ranked lower than
64% of the 1909 Companies
in the Global Health Information Services industry.

( Industry Median: 12.32 vs. OMCM: 16.62 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMCM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -95.6  Med: -5.80 Max: 170.7
Current: 16.62
-95.6
170.7
Current Ratio 0.37
OMCM's Current Ratio is ranked lower than
95% of the 1733 Companies
in the Global Health Information Services industry.

( Industry Median: 1.97 vs. OMCM: 0.37 )
Ranked among companies with meaningful Current Ratio only.
OMCM' s Current Ratio Range Over the Past 10 Years
Min: 0.02  Med: 0.15 Max: 0.98
Current: 0.37
0.02
0.98
Quick Ratio 0.37
OMCM's Quick Ratio is ranked lower than
95% of the 1733 Companies
in the Global Health Information Services industry.

( Industry Median: 1.88 vs. OMCM: 0.37 )
Ranked among companies with meaningful Quick Ratio only.
OMCM' s Quick Ratio Range Over the Past 10 Years
Min: 0.02  Med: 0.15 Max: 0.98
Current: 0.37
0.02
0.98
Days Sales Outstanding 68.44
OMCM's Days Sales Outstanding is ranked higher than
52% of the 1430 Companies
in the Global Health Information Services industry.

( Industry Median: 70.48 vs. OMCM: 68.44 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.42  Med: 39.33 Max: 151.82
Current: 68.44
22.42
151.82
Days Payable 41.93
OMCM's Days Payable is ranked lower than
52% of the 1290 Companies
in the Global Health Information Services industry.

( Industry Median: 44.10 vs. OMCM: 41.93 )
Ranked among companies with meaningful Days Payable only.
OMCM' s Days Payable Range Over the Past 10 Years
Min: 56.44  Med: 108.86 Max: 734.72
Current: 41.93
56.44
734.72

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.89
OMCM's Price/Median PS Value is ranked higher than
63% of the 2146 Companies
in the Global Health Information Services industry.

( Industry Median: 1.04 vs. OMCM: 0.89 )
Ranked among companies with meaningful Price/Median PS Value only.
OMCM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.22  Med: 1.67 Max: 200
Current: 0.89
0.22
200
Price/Graham Number 0.64
OMCM's Price/Graham Number is ranked higher than
87% of the 1540 Companies
in the Global Health Information Services industry.

( Industry Median: 8.17 vs. OMCM: 0.64 )
Ranked among companies with meaningful Price/Graham Number only.
OMCM' s Price/Graham Number Range Over the Past 10 Years
Min: 0.05  Med: 0.26 Max: 4.13
Current: 0.64
0.05
4.13
Earnings Yield (Greenblatt) (%) 5.40
OMCM's Earnings Yield (Greenblatt) (%) is ranked higher than
64% of the 1745 Companies
in the Global Health Information Services industry.

( Industry Median: 2.60 vs. OMCM: 5.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMCM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.1  Med: 7.60 Max: 14.7
Current: 5.4
2.1
14.7

More Statistics

Revenue(Mil) $20
EPS $ -0.03
Beta-0.18
Short Percentage of Float0.00%
52-Week Range $0.10 - 0.31
Shares Outstanding(Mil)92.73

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Omnicomm Systems Inc was incorporated on February 17, 1999. The Company provides web-based electronic data capture and eClinical software and services for the clinical research process. Its eClinical software and service offerings include TrialMaster, TrialOne and eClinical Suite, Promasys. Its eClinical Products are designed to allow clinical trial sponsors and investigative sites to easily and securely collect, validate, transmit, and analyze clinical study data. The eClinical Products are 21 CFR Part 11 compliant solutions and are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms, with significant flexibility, ease-of-use and with complete control over collected data. The Company also provides business process consulting services that focus on more effectively integrating EDC and eClinical Solutions and processes into the clinical trial process.Its customers include pharmaceutical, biotechnology, medical device companies, academic institutions, clinical research organizations and other entities engaged in clinical trials. The Company competes with systems and paper-based processes utilized by existing or prospective customers, as well as other commercial vendors of EDC and eClinical applications, clinical data management systems and adverse event reporting software The conduct of clinical trials is subject to regulation and regulatory guidance associated with the approval of new drugs, biological products and medical devices imposed upon the clinical trial process by the U.S. federal government and related regulatory authorities such as the U.S. Food and Drug Administration, or FDA, and by foreign governments.
» More Articles for OMCM

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
OmniComm Systems® to Present EHR to EDC eSource Strategies at eClinical Forum Webinar Feb 09 2016
OMNICOMM SYSTEMS INC Files SEC form 8-K, Unregistered Sale of Equity Securities Jan 27 2016
OmniComm Systems’ TrialMaster® EDC Technology Enables Global Biopharmaceutical Company to... Dec 28 2015
OmniComm Systems' TrialMaster(R) EDC Technology Enables Global Biopharmaceutical Company to... Dec 28 2015
OmniComm Systems Achieves Major Milestone with Over 1,500 Active TrialOne Users Worldwide Dec 16 2015
OmniComm Systems Achieves Major Milestone With Over 1,500 Active TrialOne Users Worldwide Dec 16 2015
OmniComm Systems® Named as a Top 10 Clinical Data Management Solution Provider Dec 10 2015
OmniComm Systems(R) Named as a Top 10 Clinical Data Management Solution Provider Dec 10 2015
OMNICOMM SYSTEMS INC Financials Dec 08 2015
Omnicell's (OMCL) Battles Escalating Costs: Should You Dump? Dec 07 2015
3 Reasons Value Stock Investors Will Love OmniComm Systems (OMCM) Dec 04 2015
OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of... Dec 03 2015
OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of... Dec 03 2015
OMNICOMM SYSTEMS INC Financials Nov 25 2015
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air... Nov 25 2015
5 Cheap Health Care Stocks that Promise Healthy Returns Nov 24 2015
OMNICOMM SYSTEMS INC Files SEC form 8-K, Unregistered Sale of Equity Securities Nov 20 2015
Industry Leaders Recognized for Excellence in Innovation by OmniComm Systems® Nov 20 2015
Industry Leaders Recognized for Excellence in Innovation by OmniComm Systems(R) Nov 20 2015
OMNICOMM SYSTEMS INC Files SEC form 10-Q, Quarterly Report Nov 13 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK